Novartis seeks agency to support drug launches

Drugs firm Novartis is on the hunt for a public affairs agency as it prepares to launch a record number of medicines.

Browning: ‘expanded brief’
Browning: ‘expanded brief’

The Swiss-owned company is poised to hand out a wide-ranging brief covering all aspects of its work. It has contacted six agencies and plans to begin a pitch process in early October.

Director of communications Jason Browning said he was unable to name the incumbent age­ncy due to possible repercussions with regard to ‘animal extremism’. However, he said the incumbent had been invited to repitch.

Browning, who took over in 2005, added: ‘The brief has exp­anded considerably and the level of interest is unpreceden­ted. We are launching more medicines on the NHS over the next 12 to 18 months than any other pharmaceutical company.’

Novartis recently mounted a legal challenge against the Nat­ional Institute for Health and Clinical Excellence’s decision to limit the prescribing of Alzheimer’s drugs including its Exelon product.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in